SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0000921895-18-000146
Filing Date
2018-01-12
Accepted
2018-01-12 17:20:30
Documents
4

Document Format Files

Seq Description Document Type Size
1 prec14a09271023_01112018.htm PREC14A 211132
3 GRAPHIC image_logo.jpg GRAPHIC 9306
4 GRAPHIC image_chart.jpg GRAPHIC 88732
5 filename5.htm CORRESP 6240
  Complete submission text file 0000921895-18-000146.txt   354664
Mailing Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address 290 UTAH AVE., SUITE 200 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Aviragen Therapeutics, Inc. (Subject) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: PREC14A | Act: 34 | File No.: 001-35285 | Film No.: 18526623
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 13100 GREGG STREET SUITE A POWAY CA 92064
Business Address 1048 INDUSTRIAL COURT SUWANEE GA 30024 (858) 726-1600
DIGIRAD CORP (Filed by) CIK: 0000707388 (see all company filings)

IRS No.: 330145723 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A
SIC: 3845 Electromedical & Electrotherapeutic Apparatus